Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 3, pp. 197-207
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 9, 2014
- Revision received December 29, 2014
- Accepted January 5, 2015
- Published first February 13, 2015.
Article Versions
- Previous version (February 13, 2015 - 08:22).
- You are viewing the most recent version of this article.
Copyright & Usage
©2015 American Association for Cancer Research.
Author Information
- Dmitri Madera1,
- Lynn Vitale-Cross1,
- Daniel Martin1,
- Abraham Schneider2,
- Alfredo A. Molinolo1,
- Nitin Gangane3,
- Thomas E. Carey4,
- Jonathan B. McHugh4,
- Christine M. Komarck4,
- Heather M. Walline4,
- William N. William, Jr5,
- Raja R. Seethala6,
- Robert L. Ferris7, and
- J. Silvio Gutkind1,*
- 1Molecular Carcinogenesis Section, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland.
- 2Department of Oncology and Diagnostic Sciences, School of Dentistry and Greenebaum Cancer Center, Program in Oncology, University of Maryland, Baltimore, Maryland.
- 3Department of Pathology, Mahatma Gandhi Institute of Medical Sciences, Wardha, Maharashtra, India.
- 4Department of Otolaryngology-Head Neck Surgery, and the Head and Neck SPORE Tissue Core, University of Michigan, Ann Arbor, Michigan.
- 5Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 6University of Pittsburgh School of Medicine, Pathology Program, Pittsburgh, Philadelphia.
- 7Otolaryngology, Immunology, Cancer Immunology Program, University of Pittsburgh School of Medicine, Pittsburgh, Philadelphia.
- ↵*Corresponding Author:
J. Silvio Gutkind, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, NIH, 30 Convent Drive, Building 30, Room 320, Bethesda, MD 20892. Phone: 301-496-6259; Fax: 301-402-0823; E-mail: sg39v{at}nih.gov
March 2015
Volume 8, Issue 3
Volume 8, Issue 3
Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
Jump to section
Advertisement